Insecticides (India) Ltd on Wednesday posted a consolidated net profit of ₹58 crore for the quarter ended 30 June 2025, marking a 17.4% increase from ₹49.4 crore in the same period last year.
Revenue from operations rose 5.2% year-on-year to ₹691 crore, compared with ₹657 crore in Q1 FY25. The management had given a double-digit growth guidance for the full year, the last time that they spoke to CNBC-TV18.
Earlier in May, 2025, Rajesh Aggarwal, MD of Insecticides India, attributed the weak performance in FY25 to erratic rainfall and the late timing of product launches. “There were a lot of launches, nearly one dozen launches that took place last year but most of these launches came at the fag end of the season. We did not get time to establish these products, but the response has been good,” he said.
“So, we are very, very confident that this year we should be able to register both topline and bottom-line growth,” he added.
Operating performance also improved, with EBITDA climbing 16.6% to ₹84.4 crore from ₹72.4 crore a year ago. The operating margin expanded to 12.2% from 11% in the corresponding quarter last year.
Also Read: Godrej Industries shares surge 10% after Q1 results, Godrej Capital divestment into new unit
Despite the healthy profit growth, the company’s shares saw sharp selling pressure, hitting an intraday low of ₹900, down over 11% on the NSE at 3:13 pm.
First Published: Aug 13, 2025 3:09 PM IS
